Recurrent deep venous thrombosis and systemic immune-inflammation index: The tip of the iceberg

Abstract

Get full access to this article

View all access options for this article.

References

Donmez

Muduroglu

. Systemic immune-inflammation index as a novel hematological marker for predicting the recurrence of deep venous thrombosis. Vascular 2024. Epub ahead of print. DOI: 10.1177/17085381241237146.

Aydın

Engin

. The value of inflammation indexes in predicting patency of saphenous vein grafts in patients with coronary artery bypass graft surgery. Cureus 2021; 13(7): e16646.

Miller

. Laboratory tests for the diagnosis of thrombotic disorders. Clin Obstet Gynecol 2006; 49(4): 844–849.

Guzel

Canbaz

. A retrospective assessment of venous recanalization outcomes for oral anticoagulant treatment in deep vein thrombosis. Vascular 2024. Epub ahead of print. DOI: 10.1177/17085381241236931.

Hansson

Sörbo

Eriksson

. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160(6): 769–774.

Tang

Guo

, et al. Up-and-over access is not an optimal pathway for percutaneous catheter-directed thrombolysis in acute iliofemoral popliteal venous thrombosis. Vascular 2023; 31(4): 807–812.

Tan

Mos

Klok

, et al. Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a systematic review. Br J Haematol 2011; 153(2): 168–178.